An association of overexpressed HDAC10 and HDAC7 and reduced HDAC6 and SIRT3 with poor prognosis was also noted when 200 newly diagnosed and relapsed CLL patient samples were compared with normal B cells [22]. This evidence concerns the gene HDAC7 and B-cell chronic lymphocytic leukemia.